國立虎尾科技大學 |

Neurofeedback in the Treatment of Body Dysmorphic Disorder : = A Pilot Study.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Neurofeedback in the Treatment of Body Dysmorphic Disorder :/
其他題名:	A Pilot Study.
作者:	Louison, Rebecca R.
面頁冊數:	1 online resource (147 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
Contained By:	Dissertations Abstracts International85-03B.
標題:	Therapy. -
電子資源:	click for full text (PQDT)
ISBN:	9798380345552

Neurofeedback in the Treatment of Body Dysmorphic Disorder : = A Pilot Study.
Louison, Rebecca R.

Neurofeedback in the Treatment of Body Dysmorphic Disorder :A Pilot Study. - 1 online resource (147 pages)

Source: Dissertations Abstracts International, Volume: 85-03, Section: B.

Thesis (Ph.D.)--Mount Mercy University, 2023.

Includes bibliographical references

Body Dysmorphic Disorder (BDD) is characterized by an individual's perceived flaws that are only slight or not noticeable at all by others, that cause distressing preoccupation (Biby, 1998; Flygare et al., 2020; Giannopoulos et al., 2022; Hammond & Reeve, 2020; Philips et al., 2007; Ritzert et al., 2020; Singh & Veale, 2019; Summers et al., 2020). Currently, the gold standard of care for psychological intervention with this disorder is Cognitive Behavioral Therapy (CBT) and/or pharmacological interventions of selective serotonin reuptake inhibitors (SSRI) (Flygare et al., 2020; Hammond & Reeve, 2020; Phillipou et al., 2016; Schulte et al., 2020; Singh & Veale, 2019). However, currently only 40-54% of individuals who engage in CBT report that they responded to treatment (Flygare et al., 2020), this leads to the question on if our current knowledge, awareness and efficacy with treating BDD is leading to a disservice of this population. This single subject pilot study's purpose is to explore if a QEEG guided LORETA Z Score training neurofeedback protocol, which is specific to the individual participant, could lead to a change in objective measures of the quantitative electroencephalogram (QEEG); and subjective symptoms of BDD, anxiety, depression, eating disorder, as well as Quality of Life change over the 20-session protocol. Results showed a change across most QEEG analyses over all three assessment points, along with an overall reduction in BDD symptomology, anxiety, as well as eating disorder symptomology. No change was observed in depressive symptomology. Additionally, a decrease in overall Quality of Life was observed.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798380345552Subjects--Topical Terms:

1181514
Therapy.
Subjects--Index Terms:

AnxietyIndex Terms--Genre/Form:

554714
Electronic books.

Neurofeedback in the Treatment of Body Dysmorphic Disorder : = A Pilot Study.
LDR:03055ntm a22004097 4500 001 1149372
005 20241015112531.5
006 m o d
007 cr bn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798380345552
035 $a (MiAaPQ)AAI30637487
035 $a AAI30637487
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Louison, Rebecca R. $3 1475576
245 1 0 $a Neurofeedback in the Treatment of Body Dysmorphic Disorder : $b A Pilot Study.
264 0 $c 2023
300 $a 1 online resource (147 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
500 $a Advisor: Morgan-Sowada, Heather.
502 $a Thesis (Ph.D.)--Mount Mercy University, 2023.
504 $a Includes bibliographical references
520 $a Body Dysmorphic Disorder (BDD) is characterized by an individual's perceived flaws that are only slight or not noticeable at all by others, that cause distressing preoccupation (Biby, 1998; Flygare et al., 2020; Giannopoulos et al., 2022; Hammond & Reeve, 2020; Philips et al., 2007; Ritzert et al., 2020; Singh & Veale, 2019; Summers et al., 2020). Currently, the gold standard of care for psychological intervention with this disorder is Cognitive Behavioral Therapy (CBT) and/or pharmacological interventions of selective serotonin reuptake inhibitors (SSRI) (Flygare et al., 2020; Hammond & Reeve, 2020; Phillipou et al., 2016; Schulte et al., 2020; Singh & Veale, 2019). However, currently only 40-54% of individuals who engage in CBT report that they responded to treatment (Flygare et al., 2020), this leads to the question on if our current knowledge, awareness and efficacy with treating BDD is leading to a disservice of this population. This single subject pilot study's purpose is to explore if a QEEG guided LORETA Z Score training neurofeedback protocol, which is specific to the individual participant, could lead to a change in objective measures of the quantitative electroencephalogram (QEEG); and subjective symptoms of BDD, anxiety, depression, eating disorder, as well as Quality of Life change over the 20-session protocol. Results showed a change across most QEEG analyses over all three assessment points, along with an overall reduction in BDD symptomology, anxiety, as well as eating disorder symptomology. No change was observed in depressive symptomology. Additionally, a decrease in overall Quality of Life was observed.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Therapy. $3 1181514
650 4 $a Neurosciences. $3 593561
650 4 $a Mental health. $3 564038
653 $a Anxiety
653 $a Body Dysmorphic Disorder
653 $a Depression
653 $a Eating disorder
653 $a Neurofeedback
653 $a Pilot case study
655 7 $a Electronic books. $2 local $3 554714
690 $a 0212
690 $a 0317
690 $a 0347
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Mount Mercy University. $b Marriage and Family Therapy. $3 1475577
773 0 $t Dissertations Abstracts International $g 85-03B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30637487 $z click for full text (PQDT)